My NCBI | Sign In
RSS Settings
  • Search: Arikawa E[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 24

    1.

    Cross-platform comparison of SYBR Green real-time PCR with TaqMan PCR, microarrays and other gene expression measurement technologies evaluated in the MicroArray Quality Control (MAQC) study.

    Arikawa E, Sun Y, Wang J, Zhou Q, Ning B, Dial SL, Guo L, Yang J.

    BMC Genomics. 2008 Jul 11;9:328.PMID: 18620571 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effect of cryoprotectant composition on in vitro viability of in vitro fertilized and cloned bovine embryos following vitrification and in-straw dilution.

    Taniguchi M, Ikeda A, Arikawa E, Wongsrikeao P, Agung B, Naoi H, Nagai T, Otoi T.

    J Reprod Dev. 2007 Aug;53(4):963-9. Epub 2007 Apr 10.PMID: 17420619 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effects of insulin replacements, inhibitors of angiotensin, and PKCbeta's actions to normalize cardiac gene expression and fuel metabolism in diabetic rats.

    Arikawa E, Ma RC, Isshiki K, Luptak I, He Z, Yasuda Y, Maeno Y, Patti ME, Weir GC, Harris RA, Zammit VA, Tian R, King GL.

    Diabetes. 2007 May;56(5):1410-20. Epub 2007 Mar 15.PMID: 17363743 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Effects of endothelin receptor blockade on hypervasoreactivity in streptozotocin-diabetic rats: vessel-specific involvement of thromboxane A2.

    Arikawa E, Cheung C, Sekirov I, Battell ML, Yuen VG, McNeill JH.

    Can J Physiol Pharmacol. 2006 Aug-Sep;84(8-9):823-33.PMID: 17111027 [PubMed - indexed for MEDLINE]Related articles

    5.

    Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice.

    Ohshiro Y, Ma RC, Yasuda Y, Hiraoka-Yamamoto J, Clermont AC, Isshiki K, Yagi K, Arikawa E, Kern TS, King GL.

    Diabetes. 2006 Nov;55(11):3112-20.PMID: 17065350 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Ovarian follicular and corpus luteum changes, progesterone concentrations, estrus and ovulation following estradiol benzoate/progesterone based treatment protocol in cross-bred cows.

    Taniguchi M, Ikeda A, Arikawa E, Shimizu R, Seki M, Karaki M, Rajamahendran R, Otoi T.

    Anim Reprod Sci. 2007 Jun;99(3-4):389-94. Epub 2006 Aug 14.PMID: 16989965 [PubMed - indexed for MEDLINE]Related articles

    7.

    Chronic estrogen treatment modifies insulin-induced insulin resistance and hypertension in ovariectomized rats.

    Song D, Arikawa E, Galipeau DM, Yeh JN, Battell ML, Yuen VG, McNeill JH.

    Am J Hypertens. 2005 Sep;18(9 Pt 1):1189-94.PMID: 16182108 [PubMed - indexed for MEDLINE]Related articles

    8.

    Differential regulation of angiotensin II-induced expression of connective tissue growth factor by protein kinase C isoforms in the myocardium.

    He Z, Way KJ, Arikawa E, Chou E, Opland DM, Clermont A, Isshiki K, Ma RC, Scott JA, Schoen FJ, Feener EP, King GL.

    J Biol Chem. 2005 Apr 22;280(16):15719-26. Epub 2005 Feb 7.PMID: 15699040 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Androgens are necessary for the development of fructose-induced hypertension.

    Song D, Arikawa E, Galipeau D, Battell M, McNeill JH.

    Hypertension. 2004 Mar;43(3):667-72. Epub 2004 Feb 2.PMID: 14757778 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Exaggerated coronary reactivity to endothelin-1 in diabetes: reversal with bosentan.

    Verma S, Arikawa E, Lee S, Dumont AS, Yao L, McNeill JH.

    Can J Physiol Pharmacol. 2002 Oct;80(10):980-6.PMID: 12450064 [PubMed - indexed for MEDLINE]Related articles

    11.

    Chronic thromboxane synthase inhibition prevents fructose-induced hypertension.

    Galipeau D, Arikawa E, Sekirov I, McNeill JH.

    Hypertension. 2001 Oct;38(4):872-6.PMID: 11641301 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Long-term endothelin receptor blockade improves cardiovascular function in diabetes.

    Verma S, Arikawa E, McNeill JH.

    Am J Hypertens. 2001 Jul;14(7 Pt 1):679-87.PMID: 11465653 [PubMed - indexed for MEDLINE]Related articles

    13.

    Chronic bosentan treatment improves renal artery vascular function in diabetes.

    Arikawa E, Verma S, Dumont AS, McNeill JH.

    J Hypertens. 2001 Apr;19(4):803-12.PMID: 11330884 [PubMed - indexed for MEDLINE]Related articles

    14.

    Insulin-induced vasodilation is dependent on tetrahydrobiopterin synthesis.

    Verma S, Arikawa E, Yao L, Laher I, McNeill JH.

    Metabolism. 1998 Sep;47(9):1037-9.PMID: 9751228 [PubMed - indexed for MEDLINE]Related articles

    15.

    Direct vasodepressor effects of pioglitazone in spontaneously hypertensive rats.

    Verma S, Bhanot S, Arikawa E, Yao L, McNeill JH.

    Pharmacology. 1998 Jan;56(1):7-16.PMID: 9467183 [PubMed - indexed for MEDLINE]Related articles

    16.

    Limb-girdle muscular dystrophy: clinical and pathologic reevaluation.

    Yamanouchi Y, Arikawa E, Arahata K, Ozawa E, Nonaka I.

    J Neurol Sci. 1995 Mar;129(1):15-20.PMID: 7751838 [PubMed - indexed for MEDLINE]Related articles

    17.

    Nonvacuolar myopathy in a large family with both late adult onset distal myopathy and severe proximal muscular dystrophy.

    Udd B, Rapola J, Nokelainen P, Arikawa E, Somer H.

    J Neurol Sci. 1992 Dec;113(2):214-21.PMID: 1487757 [PubMed - indexed for MEDLINE]Related articles

    18.

    Possible influences on the expression of X chromosome-linked dystrophin abnormalities by heterozygosity for autosomal recessive Fukuyama congenital muscular dystrophy.

    Beggs AH, Neumann PE, Arahata K, Arikawa E, Nonaka I, Anderson MS, Kunkel LM.

    Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):623-7.PMID: 1731332 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The frequency of patients with dystrophin abnormalities in a limb-girdle patient population.

    Arikawa E, Hoffman EP, Kaido M, Nonaka I, Sugita H, Arahata K.

    Neurology. 1991 Sep;41(9):1491-6.PMID: 1842672 [PubMed - indexed for MEDLINE]Related articles

    20.

    Immunocytochemical analysis of dystrophin in congenital muscular dystrophy.

    Arikawa E, Ishihara T, Nonaka I, Sugita H, Arahata K.

    J Neurol Sci. 1991 Sep;105(1):79-87.PMID: 1795174 [PubMed - indexed for MEDLINE]Related articles

    21.

    Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy.

    Arahata K, Beggs AH, Honda H, Ito S, Ishiura S, Tsukahara T, Ishiguro T, Eguchi C, Orimo S, Arikawa E, et al.

    J Neurol Sci. 1991 Feb;101(2):148-56.PMID: 2033400 [PubMed - indexed for MEDLINE]Related articles

    22.

    Quadriceps myopathy: forme fruste of Becker muscular dystrophy.

    Sunohara N, Arahata K, Hoffman EP, Yamada H, Nishimiya J, Arikawa E, Kaido M, Nonaka I, Sugita H.

    Ann Neurol. 1990 Nov;28(5):634-9.PMID: 2260849 [PubMed - indexed for MEDLINE]Related articles

    23.

    [A case of Becker muscular dystrophy with schizophrenic symptoms]

    Abe M, Arai M, Maehara K, Arikawa E, Arahata K.

    No To Shinkei. 1990 Nov;42(11):1061-6. Japanese. PMID: 2076351 [PubMed - indexed for MEDLINE]Related articles

    24.

    [In vitro immunoglobulin synthesis by peripheral blood mononuclear cells from patients with myasthenia gravis]

    Miyazaki Y, Arikawa E, Kubota H, Yagi K, Tanabe H.

    Rinsho Shinkeigaku. 1990 Jan;30(1):1-6. Japanese. PMID: 2331813 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    2 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity